A truncated isoform of c-Mpl with an essential C-terminal peptide targets the full-length receptor for degradation

被引:15
作者
Coers, J [1 ]
Ranft, C [1 ]
Skoda, RC [1 ]
机构
[1] Univ Basel Hosp, Dept Res Expt Hematol, CH-4031 Basel, Switzerland
关键词
D O I
10.1074/jbc.M401386200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thrombopoietin and its cognate receptor c-Mpl are the primary regulators of megakaryopoiesis and platelet production. They also play an important role in the maintenance of hematopoietic stem cells. Here, we have analyzed the function of a truncated Mpl receptor isoform (Mpl-tr), which results from alternative splicing. The mpl-tr variant is the only alternate mpl isoform conserved between mouse and humans, suggesting a relevant function in regulating Mpl signaling. Despite the presence of a signal peptide and the lack of a transmembrane domain, Mpl-tr is retained intracellularly. Our results provide evidence that Mpl-tr exerts a dominant-negative effect on thrombopoietin-dependent cell proliferation and survival. We demonstrate that this inhibitory effect is due to down-regulation of the full-length Mpl protein. The C terminus of Mpl-tr, consisting of 30 amino acids of unique sequence, is essential for the suppression of thrombopoietin-dependent proliferation and Mpl protein down-regulation. Cathepsin inhibitor-1 (CATI-1), an inhibitor of cathepsin-like cysteine proteases, counteracts the effect of Mpl-tr on Mpl protein expression, suggesting that Mpl-tr targets Mpl for lysosomal degradation. Together, these data suggest a new paradigm for the regulation of cytokine receptor expression and function through a proteolytic process directed by a truncated isoform of the same receptor.
引用
收藏
页码:36397 / 36404
页数:8
相关论文
共 48 条
[1]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[2]  
AREND WP, 1994, J IMMUNOL, V153, P4766
[3]  
ARMSTRONG J, 1990, J CELL SCI, V95, P191
[4]   The biology of stem cell factor and its receptor C-kit [J].
Ashman, LK .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (10) :1037-1051
[5]   INHIBITION OF TYROSINE KINASE-ACTIVITY OF THE EPIDERMAL GROWTH-FACTOR (EGF) RECEPTOR BY A TRUNCATED RECEPTOR FORM THAT BINDS TO EGF - ROLE FOR INTERRECEPTOR INTERACTION IN KINASE REGULATION [J].
BASU, A ;
RAGHUNATH, M ;
BISHAYEE, S ;
DAS, M .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) :671-677
[6]   zfNLRR, a novel leucine-rich repeat protein is preferentially expressed during regeneration in zebrafish [J].
Bormann, P ;
Roth, LWA ;
Andel, D ;
Ackermann, M ;
Reinhard, E .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1999, 13 (03) :167-179
[7]   IN-VITRO CHARACTERIZATION OF THE HUMAN RECOMBINANT SOLUBLE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR [J].
BROWN, CB ;
BEAUDRY, P ;
LAING, TD ;
SHOEMAKER, S ;
KAUSHANSKY, K .
BLOOD, 1995, 85 (06) :1488-1495
[8]   TARGETING OF THE YEAST PLASMA-MEMBRANE [H+]ATPASE - A NOVEL GENE AST1 PREVENTS MISLOCALIZATION OF MUTANT ATPASE TO THE VACUOLE [J].
CHANG, A ;
FINK, GR .
JOURNAL OF CELL BIOLOGY, 1995, 128 (1-2) :39-49
[9]   INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME [J].
DALEY, GQ ;
VANETTEN, RA ;
BALTIMORE, D .
SCIENCE, 1990, 247 (4944) :824-830
[10]   ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT [J].
EVAN, GI ;
LEWIS, GK ;
RAMSAY, G ;
BISHOP, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3610-3616